Drug Development from Natural Products Based on the Pathogenic Mechanism of Asthma
Asthma is a chronic inflammatory disease of the pulmonary system associated with many wheeze-to-sleep apnea complications that may lead to death. In 2019, approximately 262 million patients suffered from asthma, and 455 thousand died from the disease worldwide. It is a more severe health problem in...
Main Authors: | Min-Hee Kim, Chun-Sik Bae, So-Hyeon Bok, Hyo-Seung Choi, Taeho Ahn, Seung-Sik Cho, Dae-Hun Park |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/15/12469 |
Similar Items
-
Hallucination Development with Montelukast in a Child with Asthma: Case Presentation
by: Aysen Kocyigit, et al.
Published: (2013-12-01) -
Epigenetic Changes in Asthma: Role of DNA CpG Methylation
by: Da-Jeong Bae, Ph.D., et al.
Published: (2020-01-01) -
ROLE OF ANTILEUKOTRIENE DRUGS IN ACHIEVEMENT OF BRONCHIAL ASTHMA CONTROL
by: N. M. Nenasheva
Published: (2017-11-01) -
Asthma in focus /
by: 186684 Murphy, Anna
Published: (2007) -
Interactions of Nanoparticles with Macrophages and Feasibility of Drug Delivery for Asthma
by: Sung Hun Kang, et al.
Published: (2022-01-01)